Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours

Only about half of patients with a poor-prognosis non-seminomatous germ-cell tumours can achieve a cure. The aim of this phase II study was to assess the efficacy and toxicity of a dose-dense alternating chemotherapy regimen in this subset of patients. High volume non-seminomatous germ-cell tumours...

Descripción completa

Detalles Bibliográficos
Autores principales: Fizazi, K, Prow, D M, Do, K-A, Wang, X, Finn, L, Kim, J, Daliani, D, Papandreou, C N, Tu, S-M, Millikan, R E, Pagliaro, L C, Logothetis, C J, Amato, R J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746595/
https://www.ncbi.nlm.nih.gov/pubmed/12085204
http://dx.doi.org/10.1038/sj.bjc.6600272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746595/
https://www.ncbi.nlm.nih.gov/pubmed/12085204
http://dx.doi.org/10.1038/sj.bjc.6600272

Ejemplares similares